Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-005464

CVP, TAVR sold 620 shares at $81.14 ($50,307)

  • CVP, TAVR acquired 620 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lippis Daniel J. · CVP, TAVR

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-18 Exercise or conversion : show line 1 in the form 10b5-1 +620 $72.68 $45,062 41,030.91 D
2026-05-18 Sale : show line 2 in the form 10b5-1 −620 $81.14 $50,307 40,410.91 D
Open-market sales · 620 sh · avg $81.14 · $50,307

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-18 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −620 6,190 D
Loading xslF345X06/doc4.xml…